Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel C Jankowitz

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer StudyRoisin M Connolly, Huili Li, Rachel C Jankowitz, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain MetastasesRachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2016
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer StudyRoisin M Connolly, Huili Li, Rachel C Jankowitz, et al.
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2019
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain MetastasesRachel A Freedman, Rebecca S Gelman, Carey K Anders, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.
Pageof 6